MediWales is delighted to launch the Natural Compounds Special Interest Group (SIG) alongside its collaborative partners. The SIG will be a forum that is used to discuss and support the development and commercialisation of natural products for health, wellbeing and disease management.
The aim is to provide a follow-on forum that augments existing research-focused interest groups so that findings from research environments can be transferred into commercialised products. The focus of this SIG will therefore be on taking natural compounds that have already been identified and for which research data already exists, to market.
The group will share advice on developing routes to market,managing regulatory requirements, achieving relevant product certifications and running clinical trials.
Key note speakers include:
- Dr Joerg Gruenwald, Founder and Chief Scientific Advisor at Analyze & Realize GmbH and President of Herbalist & Doc GmbH
- Michael Graz, Managing Director of Neem Biotech
To find out more information about this event and to register your place, please click here.